House Bill 1463 establishes the Task Force on Diabetes Management within the Department of Health to evaluate the need for a referral program for individuals diagnosed with diabetes to access treatment at federally qualified health centers, irrespective of their health coverage. The task force will create referral criteria and is required to report its findings to the Governor and Legislature by May 1, 2026. The State Surgeon General has the authority to reestablish the task force if needed, and by January 1, 2027, must implement the recommended program unless certain conditions are met.

The bill also amends existing laws to allow pharmacists to prescribe and dispense a 30-day supply of insulin and diabetes-related devices under specific conditions, ensuring that patients are not charged more than their insurance copayment or the usual cost if uninsured. It mandates health insurance policies to cover laboratory testing and screening for diabetes without certain cost-sharing requirements and introduces definitions for various diabetes-related terms. Additionally, it sets cost-sharing limits for insulin and diabetes devices and requires health maintenance contracts to follow the same coverage provisions as health insurance policies. The act is set to take effect on July 1, 2025, and applies to all relevant health insurance policies and contracts from January 1, 2026.